TIBOTEC PHARMACEUTICALS LTD.
Patent Owner
Stats
- 65 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Feb 03, 2015 most recent publication
Details
- 65 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 859 Total Citation Count
- Jul 13, 1994 Earliest Filing
- 49 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
8546076 Mutational profile in HIV-1 GAG cleavage site correlated with phenotypic drug resistanceExpiredJun 21, 12Oct 01, 13[C12Q]
2012/0220,520 BIOAVAILABLE COMBINATIONS FOR HCV TREATMENTAbandonedJan 26, 07Aug 30, 12[A61K, C07D, A61P]
8076062 Mutational profiles in HIV-1 protease correlated with phenotypic drug resistanceExpiredOct 30, 08Dec 13, 11[C12Q]
8076513 Methods for the preparation of N-isobutyl-N-(2-hydroxy-3-amino-4-phenylbutyl)-p-nitrobenzenesulfonylamide derivativesExpiredApr 25, 08Dec 13, 11[C07C]
2011/0275,654 LONG TERM TREATMENT OF HIV-INFECTION WITH TMC278AbandonedJan 19, 07Nov 10, 11[A61K, A61P]
7994187 HIV inhibiting 3,4-dihydro-imidazo[4,5-B]pyridin-5-onesExpiredApr 03, 07Aug 09, 11[A61K, C07D]
2010/0280,268 HOMOGENEOUS TIME RESOLVED FLUORESCENCE BASED TEST SYSTEMAbandonedApr 06, 07Nov 04, 10[C07C, G01N]
2010/0261,751 METHOD FOR DETERMINING ONE OF THE TWO HUMAN IMMUNODEFICIENCY VIRUS (HIV) INTEGRASE ENZYMATIC ACTIVITIESAbandonedDec 05, 08Oct 14, 10[A61K, C12Q, C07D, A61P]
2010/0173,282 MUTATIONAL PROFILE IN HIV-1 GAG CLEAVAGE SITE CORRELATED WITH PHENOTYPIC DRUG RESISTANCEAbandonedMay 23, 08Jul 08, 10[C12Q, C12N, G06F, C07K]
2010/0173,381 CRYSTAL STRUCTURES OF HIV-1 PROTEASE INHIBITORS BOUND TO HIV-1 PROTEASEAbandonedDec 18, 07Jul 08, 10[C12N, G06G]
7659404 Broad spectrum 2-(substituted-amino)-benzothiazole sulfonamide HIV protease inhibitorsExpiredFeb 14, 02Feb 09, 10[A61K, C07D]
2010/0009,341 METHODS AND MEANS FOR ASSESSING HIV GAG/PROTEASE INHIBITOR THERAPYAbandonedApr 13, 07Jan 14, 10[C07H, C12Q, C12P, C12N]
7622490 Broadspecturm 2-amino-benzoxazole sulfonamide HIV protease inhibitorsExpiredMay 10, 02Nov 24, 09[A61K, C07D]
7622581 6,7,8,9-substituted 1-phenyl-1,5-dihydro-pyrido[3,2-b]indol-2-ones useful as anti-infective pharmaceutical agentsExpiredMay 17, 05Nov 24, 09[C07D]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.